April 12, 2021 | Board Member (No Photo Displayed)| Leadership
Matthew Gantz is President and Chief Executive Officer of Castle Creek Biosciences, Inc., and a member of the company’s Board of Directors. An accomplished life sciences executive with more than 25 years of experience in the specialty biopharmaceutical and medical device industries, Mr. Gantz previously served as Chief Executive Officer of OxThera AB. Prior to […]
Read MoreDecember 12, 2022 | CCB People| Leadership
Tim Cunniff, PharmD, serves as executive vice president of research and development, overseeing all scientific, clinical and regulatory matters associated with new product development, approvals and maintenance. He has over 30 years of experience in clinical development, pharmacovigilance, quality assurance and regulatory affairs. Previously, he served as executive vice president of research & development at […]
Read MoreDecember 12, 2022 | CCB People| Leadership
Mark Hurtt, M.D. is Interim Chief Medical Officer of Castle Creek Biosciences. He has been a clinical research consultant to biotechnology companies for more than a decade, focusing on clinical and regulatory strategies for the approval of cell and gene therapies for rare and ultra-rare diseases. Before practicing as a consultant, he was Chief Medical […]
Read MoreFebruary 08, 2023 | Leadership
Christopher Ballas is Chief Technology Officer at Castle Creek Biosciences, Inc. He has over 25 years of experience with cell and gene therapies in academic and industry roles covering research, development, testing, and manufacturing of viral vectors and cell therapies. Dr. Ballas recently was the Sr. Vice President of Manufacturing for Innovative Cellular Therapeutics. Prior […]
Read MoreJuly 02, 2020 | Leadership
Mr. Hesselberg is Senior Vice President of Regulatory Affairs at Castle Creek Biosciences, Inc. He brings more than 30 years of experience in the biopharmaceutical industry, including over 20 years in regulatory affairs drug and biologics development. Prior to joining Castle Creek, Mr. Hesselberg held various leadership positions at Immunex Corporation, ICOS Corporation, GTX Inc, […]
Read More